Search Results 111-120 of 9821 for Nuedexta

  1. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  2. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

  3. SC16LD6.5 in Recurrent Small Cell Lung Cancer - Mayo Clinic

    5 will be assessed by measuring the extent of tumor shrinkage. SC16LD6.5 is an antibody-drug conjugate (ADC). The antibody (SC16) targets a protein that appears ...

  4. A Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects with Lewy Body Dementia - Mayo Clinic

    Inclusion Criteria. Adult aged 50 and older; Diagnosis of Lewy body dementia based on DSM-5 diagnostic criteria or diagnosis of Parkinson's disease dementia ...

  5. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  6. A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

    A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; ...

  7. Friedreich's Ataxia Clinical Trials - Mayo Clinic Research

    The primary purpose of this dose-ranging study is to assess the safety and tolerability of 3 ascending doses of LX2006 gene therapy for the purpose of selecting ...

  8. Neurology - Clinical trials - Mayo Clinic

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  9. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    About this study. This study is being conducted to see if adding Exemestane to the immune checkpoint blockade can slow disease progression in ...

  10. https://www.mayoclinic.org/spanish_patient_consumer_web.xml